3rd Annual Orphan Drug Summit
Driving business performance through partnering, networking and in-depth discussion
July 24 - 26, 2012
London UK
Improve your market access and commercialisation strategies
Seven years after its inception the European Union (EU) regulation on Orphan Medicinal Products has yielded over 500 orphan designations leading to some 45 orphan drugs been approved for marketing in the EU. Of these 500 over 60% were developed by leading companies or institutions based in Europe.
More information about 3rd Annual Orphan Drug Summit »
